coronary heart disease

By Laura Lovett February 15, 2018
Yesterday, Redwood City, California-based HeartFlow, a company that specializes in creating computerized heart models to treat coronary diseases, announced that it landed $240 million in series E funding led by Wellington Management Company and Baillie Gifford & Company.  “This financing will enable us to drive commercial success of the HeartFlow Analysis, which is poised to become the global...
By Jonah Comstock September 24, 2015
A relatively large randomized control trial in Australia has shown that a text messaging program can improve not only health behaviors, but actually affect health outcomes. The 2-year study of 710 patients with coronary heart disease, published in the Journal of the American Medical Association showed that six months of a text messaging intervention produced significant reduction in cholesterol,...

Editor's Pick